Adapalene and doxorubicin synergistically promote apoptosis of tnbc cells by hyperactivation of the erk1/2 pathway through ros induction

HIGHLIGHTS

  • who: Umar Mehraj from the Indian Institute of Technology, Research University, India have published the paper: Adapalene and Doxorubicin Synergistically Promote Apoptosis of TNBC Cells by Hyperactivation of the ERK1/2 Pathway Through ROS Induction, in the Journal: (JOURNAL)
  • what: Presently, BC is the main reason for global tumor-related deaths . The authors investigated the anti-tumor potential of ADA in TNBC in_vitro models and whether ADA can enhance the antitumor efficacy of doxorubicin in TNBC cells. The study demonstrates that ADA, either Frontiers in Oncology | www.frontiersin.org July 2022 | Volume 12 | Article 938052 . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?